MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$110,635K
Provision for income taxes
$1,552K
Loss before
provision for income taxes
-$109,083K
Interest income, net
$5,333K
Other (income)
expense, net
-$54K
Total operating
expenses
$114,362K
General and
administrative
$15,438K
Research and development
$98,924K
Back
Back
Income Statement
source: myfinsight.com
Immunovant, Inc. (IMVT)
Immunovant, Inc. (IMVT)